nine adult patients with obstructive sleep apnea syndrome were administered medroxyprogesterone acetate , 60 to 120 mg/day , and the effect of medroxyprogesterone on clinical symptoms and obstructive apneas during sleep was assessed .
C0065864
medroxyprogesterone acetate
C0025147
medroxyprogesterone